Illumina Inc. (ILMN): Price and Financial Metrics

Illumina Inc. (ILMN): $219.77

-4.78 (-2.13%)

POWR Rating

Component Grades













Add ILMN to Watchlist
Sign Up

Industry: Biotech



in industry


  • ILMN scores best on the Quality dimension, with a Quality rank ahead of 52.01% of US stocks.
  • The strongest trend for ILMN is in Value, which has been heading down over the past 178 days.
  • ILMN's current lowest rank is in the Growth metric (where it is better than 4.81% of US stocks).

ILMN Stock Summary

  • ILMN has a market capitalization of $35,478,900,000 -- more than approximately 93.75% of US stocks.
  • The price/operating cash flow metric for ILLUMINA INC is higher than 95.97% of stocks in our set with a positive cash flow.
  • In terms of twelve month growth in earnings before interest and taxes, ILLUMINA INC is reporting a growth rate of -556.09%; that's higher than just 3.32% of US stocks.
  • If you're looking for stocks that are quantitatively similar to ILLUMINA INC, a group of peers worth examining would be AEM, GOLD, SSRM, GORO, and MUX.
  • Visit ILMN's SEC page to see the company's official filings. To visit the company's web site, go to

ILMN Valuation Summary

  • ILMN's price/sales ratio is 7.7; this is 63.83% higher than that of the median Healthcare stock.
  • Over the past 243 months, ILMN's price/sales ratio has gone down 3.5.

Below are key valuation metrics over time for ILMN.

Stock Date P/S P/B P/E EV/EBIT
ILMN 2023-03-17 7.7 5.4 -8.1 -8.6
ILMN 2023-03-16 7.8 5.4 -8.1 -8.6
ILMN 2023-03-15 7.9 5.5 -8.2 -8.7
ILMN 2023-03-14 7.8 5.4 -8.1 -8.6
ILMN 2023-03-13 7.8 5.4 -8.1 -8.7
ILMN 2023-03-10 6.7 4.6 -7.0 -7.5

ILMN Growth Metrics

    Its year over year net cashflow from operations growth rate is now at -59.76%.
  • Its 4 year revenue growth rate is now at 46.66%.
  • The year over year cash and equivalents growth rate now stands at -69.52%.
Over the past 52 months, ILMN's revenue has gone up $1,342,000,000.

The table below shows ILMN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 4,584 392 -4,404
2022-09-30 4,699 527 -4,153
2022-06-30 4,692 307 -20
2022-03-31 4,656 435 700
2021-12-31 4,526 545 762
2021-09-30 4,280 669 906

ILMN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ILMN has a Quality Grade of B, ranking ahead of 94.64% of graded US stocks.
  • ILMN's asset turnover comes in at 0.489 -- ranking 48th of 75 Measuring and Control Equipment stocks.
  • AMOT, AATC, and TRMB are the stocks whose asset turnover ratios are most correlated with ILMN.

The table below shows ILMN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-04 0.489 0.686 0.187
2021-04-04 0.448 0.676 0.175
2021-01-03 0.439 0.680 0.173
2020-09-27 0.443 0.690 0.165
2020-06-28 0.464 0.703 0.174
2020-03-29 0.497 0.704 0.209

ILMN Price Target

For more insight on analysts targets of ILMN, see our ILMN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $459.00 Average Broker Recommendation 1.92 (Hold)

ILMN Stock Price Chart Interactive Chart >

Price chart for ILMN

ILMN Price/Volume Stats

Current price $219.77 52-week high $371.16
Prev. close $224.55 52-week low $173.45
Day low $216.85 Volume 1,144,471
Day high $223.82 Avg. volume 1,409,017
50-day MA $209.03 Dividend yield N/A
200-day MA $207.77 Market Cap 34.72B

Illumina Inc. (ILMN) Company Bio

Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencinggenotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California. (Source:Wikipedia)

ILMN Latest News Stream

Event/Time News Detail
Loading, please wait...

ILMN Latest Social Stream

Loading social stream, please wait...

View Full ILMN Social Stream

Latest ILMN News From Around the Web

Below are the latest news stories about ILLUMINA INC that investors may wish to consider to help them evaluate ILMN as an investment opportunity.

3 Cutting-Edge Healthcare Stocks That Can Pay Off Big Time

For investors betting on healthcare, look for these three companies to provide the treatments of tomorrow.

John Blankenhorn on InvestorPlace | March 18, 2023

Buy This Magnificent Growth Stock Before It's Too Late

Bionano Genomics (NASDAQ: BNGO) appears to be in just that place -- at the start of its growth journey -- and it could be a great way to give your portfolio some additional upside potential. Bionano's claim to fame is its laboratory analyzer device for optical genome mapping, which it calls the Saphyr.

Yahoo | March 16, 2023

ChatGPT Says These 7 Stocks Could Be the Next Trillion-Dollar Companies

Are you looking for the next trillion-dollar companies?

Samuel O'Brient on InvestorPlace | March 15, 2023

Icahn urges Illumina to unwind Grail deal, pushes ahead on proxy fight

In his second letter to Illumina shareholders this week, Icahn wrote the "only path forward is for Grail to be divested". Illumina said on Monday it will divest Grail, which it purchased in 2021, if it loses its appeal to the European Commission where regulators said last year they intend to require Illumina to unwind the $7.1 billion takeover. Icahn, who owns 1.4% of Illumina, launched a proxy fight earlier this week and is seeking three board seats at the company after weeks of private discussions with Illumina sputtered.

Yahoo | March 15, 2023

Illumina (ILMN) Unveils Complete Long Reads Technology

Illumina's (ILMN) Complete Long Read Prep combines Illumina sequencing by synthesis chemistry with DRAGEN secondary analysis to provide WGS with more accuracy.

Yahoo | March 15, 2023

Read More 'ILMN' Stories Here

ILMN Price Returns

1-mo 3.75%
3-mo 14.79%
6-mo 10.90%
1-year -36.50%
3-year -9.19%
5-year -10.97%
YTD 8.69%
2022 -46.85%
2021 2.82%
2020 11.53%
2019 10.61%
2018 37.27%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7873 seconds.